Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Endometrial Neoplasms × Metformin × Clear all

Phase

Phase 2 6 Phase EARLY_PHASE1 2 Phase NA 1 Phase 4 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 41 Insulin Resistance 12 Metabolic Syndrome 4 Obesity 3 Hyperandrogenism 3 Breast Neoplasms 3 Weight Loss 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Infertility, Female 2 Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Rare Diseases 1 Prostatic Neoplasms 1 Obesity, Morbid 1 Metformin 1 Menstruation Disturbances 1 Inflammation 1 Infertility 1 Hyperinsulinism 1 Hyperglycemia 1 Head and Neck Neoplasms 1 Glucose Intolerance 1 Endometrial Neoplasms 1 Endocrine System Diseases 1 Diabetes Mellitus 1 Depression 1 Colorectum 1

Interventions

Early Intervention, Educational 7 Surveys and Questionnaires 6 Indocyanine Green 6 Sentinel Lymph Node Biopsy 5 Methods 5 Lymph Node Excision 5 Exercise 5 Counseling 5 Robotic Surgical Procedures 4 Genetic Testing 4 Radiotherapy 3 Radiation 3 Psychiatric Rehabilitation 3 Motivational Interviewing 3 Diet 3 Blood Specimen Collection 3 Behavior Therapy 3 iso-sulfan blue 2 Videotape Recording 2 Trehalase 2 Therapeutics 2 Surgical Procedures, Operative 2 Standard of Care 2 Palliative Care 2 Paclitaxel 2 Megestrol Acetate 2 Laparoscopy 2 Interviews as Topic 2 Injections 2 Genetic Counseling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03538704 2018-05-29

ECFerSp

Peking University People's Hospital

Phase NA Unknown

Recurrence, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡